Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience

Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication in patients receiving antiresorptive therapies for bone neoplastic localizations and osteoporosis. The aim of this study was to evaluate the clinicopathological features of MRONJ in a cohort of patients treated by new anti...

Full description

Bibliographic Details
Main Authors:	Gianfranco Favia, Angela Tempesta, Luisa Limongelli, Vito Crincoli, Eugenio Maiorano
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	International Journal of Dentistry
Online Access:	http://dx.doi.org/10.1155/2016/1801676

Similar Items

New Dimensional Staging of Bisphosphonate-Related Osteonecrosis of the Jaw Allowing a Guided Surgical Treatment Protocol: Long-Term Follow-Up of 266 Lesions in Neoplastic and Osteoporotic Patients from the University of Bari
by: Simonetta Franco, et al.
Published: (2014-01-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019-12-01)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019-11-01)

Massive Lingual and Sublingual Haematoma following Postextractive Flapless Implant Placement in the Anterior Mandible
by: Luisa Limongelli, et al.
Published: (2015-01-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Serum biomarkers for antiresorptives-related osteonecrosis of the jaw: In vivo and clinical validation studies
by: Hye-Yeon Kim, et al.
Published: (2020-10-01)

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
by: Roberto Sacco, et al.
Published: (2021-01-01)

Peripheral Giant Cell Granuloma of the Jaws as First Sign of Primary Hyperparathyroidism: A Case Series
by: Luisa Limongelli, et al.
Published: (2020-12-01)

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
by: Kununya Pimolbutr, et al.
Published: (2018-01-01)

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw
by: Sandra Bacián Martínez, et al.
Published: (2021-08-01)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
by: Giacomo Oteri, et al.
Published: (2018-01-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

Posible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report
by: P. Selvi Sabater, et al.
Published: (2014-05-01)

Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
by: Higuchi, T., et al.
Published: (2018)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
by: Julian Woolley, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.
by: Takuma Watanabe, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
by: Watanabe, Takuma
Published: (2021)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
by: Camilla Ottesen, et al.
Published: (2020-04-01)

Antiresorptive activity of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis
by: Nadezhda Y. Banshchikova, et al.
Published: (2018-12-01)

Fine‐needle aspiration cytology in head and neck diagnosis
by: Angela Tempesta, et al.
Published: (2019-03-01)

Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
by: Pramod S Sankar, et al.
Published: (2018-01-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Early Detection of Antiresorptive drug-Related Osteonecrosis of the Jaws (ARONJ) with Technetium-99m Methylene Diphosphonate-based Bone Scintigraphy
by: Anna Marie J. Miranda, et al.
Published: (2015)

Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case
by: Mohammed Qaisi, et al.
Published: (2016-01-01)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
by: Masaki Minabe, et al.
Published: (2020-12-01)

Clinical aspects and considerations in patients with medication-induced osteonecrosis of the jaw: A commentary
by: Adarsh Kudva, et al.
Published: (2020-01-01)

Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
by: Mampei Kawahara, et al.
Published: (2021-05-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Aminogam<sup>®</sup> Gel Allows Faster Wound Healing after Oral Surgery by Formation of Mature Connective Tissue with Low Vascular Density and Reducing Inflammatory Infiltration. A Retrospective Study on 580 Cases with Histological and Confocal Laser Investigation
by: Saverio Capodiferro, et al.
Published: (2020-02-01)

Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016-01-01)

A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva<sup>®</sup>) Related Osteonecrosis of the Jaw: A Retrospective Study
by: Zineb Assili, et al.
Published: (2021-05-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: a case series analysis and literature review
by: Alessandra Raimondi, et al.
Published: (2020-10-01)

A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers
by: Satoe Okuma, et al.
Published: (2020-05-01)